[
    {
        "_id": "1",
        "additionalinformations": "If diluted mix with Dextrose 5% (for infusion use 100 mL D5W)\r\nMay be flushed with NaCl.\r\n\r\nFor adult cardiac arrest do not dilute, administer directly followed by a flush.\r\n\r\nFor ease of use in paediatric calculations, when using 150 mg in 3 mL, add 2 mL D5W, making\r\nthe concentration 150 mg in 5 mL.",
        "adultdose": "VF/VT: 5 mg/Kg IV/IO (loading dose for cardiac arrest: 300 mg and 150 mg supplementary dose).\r\n\r\nSymptomatic tachycardia: 150 mg IV (in 100 mL D5W).",
        "contraindications": "Known hypersensitivity to Iodine, KSAR.",
        "indications": "Ventricular fibrillation (VF), ventricular tachycardia ( pVT), symptomatic ventricular tachycardia (>150).",
        "mdccreatedate": "20/09/2013 07:10:37",
        "mdcid": "1",
        "mdcmodifieddate": "19/11/2016 08:20:00",
        "medicinename": "Amiodarone",
        "paediatricdose": "VF/VT: 5 mg/Kg IV/IO.",
        "sideeffects": "Inflammation of peripheral veins, Bradycardia and AV conducting abnormalities."
    },
    {
        "_id": "2",
        "additionalinformations": "Also called Glucose...\r\n\r\nCannula patency will reduce the effect of tissue necrosis.",
        "adultdose": "250 mL IV/IO infusion (repeat x 1 prn).",
        "contraindications": "KSAR.",
        "indications": "Hypoglycaemic emergency. Blood glucose < 4 mmol/L..",
        "mdccreatedate": "20/09/2013 07:10:37",
        "mdcid": "2",
        "mdcmodifieddate": "19/11/2016 08:17:53",
        "medicinename": "Dextrose 10% solution",
        "paediatricdose": "5 mL/Kg IV/IO (repeat x 1 prn).",
        "sideeffects": "Necrosis of tissue around IV access."
    },
    {
        "_id": "3",
        "additionalinformations": "Diazepam IV/IO should be titrated to effect. \r\n\r\nThe maximum dose of Diazepam includes that administered by carer prior to arrival of Practitioner.",
        "adultdose": "5 mg IV/IO (repeat x 1 prn).",
        "contraindications": "Respiratory depression, KSAR, shock, depressed vital signs or alcohol related ALoC.",
        "indications": "Seizure.",
        "mdccreatedate": "20/09/2013 07:10:37",
        "mdcid": "3",
        "mdcmodifieddate": "19/11/2016 08:20:31",
        "medicinename": "Diazepam",
        "paediatricdose": "0.1 mg/Kg IV/IO (repeat x 1 prn).",
        "sideeffects": "Hypotension, respiratory depression, drowsiness and light-headedness (the next day)."
    },
    {
        "_id": "4",
        "additionalinformations": "N.B. Double check concentrations on pack before use.",
        "adultdose": "Cardiac arrest: 1 mg IV/IO (repeat 3-5 min prn).",
        "contraindications": "KSAR.",
        "indications": "Cardiac arrest.\r\n\r\nPaediatric bradycardia unresponsive to other measures.",
        "mdccreatedate": "20/09/2013 07:10:37",
        "mdcid": "4",
        "mdcmodifieddate": "03/11/2014 03:49:13",
        "medicinename": "Epinephrine (1:10,000)",
        "paediatricdose": "Cardiac arrest: 0.01 mg/Kg (0.1 mL/Kg) IV/IO (repeat 3-5 min prn).\r\n\r\nBradycardia: 0.01 mg/Kg (0.1 mL/Kg) IV/IO (repeat every 3-5 mins prn).",
        "sideeffects": "In non-cardiac arrest patients: palpitations, tachyarrhythmias, hypertension."
    },
    {
        "_id": "5",
        "additionalinformations": "Caution if patient has transdermal Fentanyl patch.\r\n\r\nDosage calculator includes an additional 0.1 mL to allow for MAD dead space.\r\n\r\nAdminister 50% volume in each nostril if more than 1 mL.",
        "adultdose": "0.1 mg IN. (repeat x 1 after 10 minutes if severe pain persists).",
        "contraindications": "Known Fentanyl hypersensitivity, altered level of consciousness, bilateral occluded nasal passage, nasal trauma, Epistaxis, Hypovolaemia.",
        "indications": "Acute severe pain in patients ≥ 1 year old.",
        "mdccreatedate": "20/09/2013 07:10:37",
        "mdcid": "5",
        "mdcmodifieddate": "03/11/2014 03:49:39",
        "medicinename": "Fentanyl",
        "paediatricdose": "0.0015 mg/Kg (1.5 mcg/Kg) IN. (repeat x 1 after 10 minutes if severe pain persists.)",
        "sideeffects": "Sedation, nausea, vomiting, respiratory depression."
    },
    {
        "_id": "6",
        "additionalinformations": "If Ibuprofen administered in previous 6 hours, adjust the dose downward by the amount given by other sources resulting in a maximum of 10 mg/Kg.\r\n\r\nCaution with significant burns or poor perfusion due to risk of kidney failure.\r\n\r\nCaution if concurrent NSAIDs use.",
        "adultdose": "400 mg PO.",
        "contraindications": "Not suitable for children under 3 months, patient with history of asthma exacerbated by Aspirin, pregnancy, peptic ulcer disease, KSAR.",
        "indications": "Mild to moderate pain.",
        "mdccreatedate": "20/09/2013 07:10:37",
        "mdcid": "6",
        "mdcmodifieddate": "03/11/2014 03:28:44",
        "medicinename": "Ibuprofen",
        "paediatricdose": "10 mg/Kg PO.",
        "sideeffects": "Skin rashes, gastrointestinal intolerance and bleeding."
    },
    {
        "_id": "7",
        "additionalinformations": "Midazolam IV should be titrated to effect.\r\n\r\nEnsure oxygen and resuscitation equipment are available prior to administration.\r\n\r\nNo more than two doses by practitioners.\r\n\r\nPractitioners should take into account the dose administered by carers prior to arrival of practitioner.\r\n\r\nContraindications, other than KSAR, refer to non seizing patients.",
        "adultdose": "Seizure or combative patient:\r\n2.5 mg IV/IO (AP) or 5 mg IM or 10 mg buccal or 5 mg intranasal (P & AP).\r\n(repeat x 1 prn).\r\n\r\nParamedic: IM, buccal or IN only.",
        "contraindications": "Shock, depressed vital signs or alcohol-related ALoC, respiratory depression, KSAR.",
        "indications": "Seizures, combative with hallucinations or paranoia and risk to self or others.",
        "mdccreatedate": "20/09/2013 07:10:37",
        "mdcid": "7",
        "mdcmodifieddate": "16/04/2015 10:49:46",
        "medicinename": "Midazolam Solution",
        "paediatricdose": "Seizure:\r\n< 1year: 2.5 mg buccal\r\n1 year to < 5 years: 5 mg buccal\r\n5 years to < 10 years: 7.5 mg buccal\r\n≥ 10 years: 10 mg buccal.\r\nor\r\n0.2 mg/Kg intranasal or 0.1 mg/Kg IV/IO.\r\n(repeat x 1 prn).\r\n\r\nParamedic: buccal or IN only.",
        "sideeffects": "Respiratory depression, headache, hypotension, drowsiness."
    },
    {
        "_id": "8",
        "additionalinformations": "Use with extreme caution particularly with elderly/young.\r\n\r\nCaution with acute respiratory distress.\r\n\r\nCaution with reduced GCS.\r\n\r\nNot recommended for headache.\r\n\r\nN.B. Controlled under Misuse of Drugs Act (1977, 1984).",
        "adultdose": "2 mg IV/IO (repeat at not < 2 min intervals prn to max 10 mg, or for musculoskeletal pain max 16 mg).\r\n\r\nUp to 10 mg IM (if not cardiac chest pain and no IV access).",
        "contraindications": "PO < 1 year, KSAR, labour pains, acute respiratory depression, acute intoxication, systolic BP < 90 mmHg.",
        "indications": "Adult: Severe pain (≥ 7 on pain scale)\r\n\r\nPaediatric: Severe pain (≥ 7 on pain scale)",
        "mdccreatedate": "20/09/2013 07:10:37",
        "mdcid": "8",
        "mdcmodifieddate": "22/10/2014 11:01:53",
        "medicinename": "Morphine",
        "paediatricdose": "0.3 mg/Kg PO (max 10 mg)\r\n\r\n0.05 mg/Kg IV/IO (repeat at not < 2 min intervals prn to max 0.1 mg/Kg).",
        "sideeffects": "Respiratory depression, drowsiness, nausea and vomiting, constipation."
    },
    {
        "_id": "9",
        "additionalinformations": "Use with caution in pregnancy.\r\n\r\nAdminister with caution to patients who have taken large dose of narcotics or are physically dependent.\r\n\r\nRapid reversal will precipitate acute withdrawal syndrome.\r\n\r\nPrepare to deal with aggressive patients.",
        "adultdose": "0.4 mg IV/IO (AP)\r\n\r\n0.4 mg IM/SC (P)\r\n\r\n0.8 mg IN (EMT) \r\n\r\nAll: Repeat after 3 min prn to max 2 mg.",
        "contraindications": "KSAR.",
        "indications": "Inadequate respirations and/or ALoC following known or suspected narcotic overdose.",
        "mdccreatedate": "20/09/2013 07:10:37",
        "mdcid": "9",
        "mdcmodifieddate": "03/11/2014 12:52:21",
        "medicinename": "Naloxone",
        "paediatricdose": "0.01 mg/Kg IV/IO (AP)\r\n\r\n0.01 mg/Kg IM/SC (P)\r\n\r\n0.02 mg/Kg IN (EMT)\r\n\r\nAll: Repeat prn to maintain opioid reversal to max 0.1 mg/Kg or 2 mg.",
        "sideeffects": "Acute reversal of narcotic effect ranging from nausea and vomiting to agitation and seizures."
    },
    {
        "_id": "10",
        "additionalinformations": "",
        "adultdose": "4 mg slow IV.",
        "contraindications": "KSAR.",
        "indications": "Management, prevention and treatment of nausea and vomiting.",
        "mdccreatedate": "20/09/2013 07:10:37",
        "mdcid": "10",
        "mdcmodifieddate": "04/12/2013 02:57:08",
        "medicinename": "Ondansetron",
        "paediatricdose": "0.1 mg/Kg IV slowly to Max of 4 mg.",
        "sideeffects": "Headache, sensation of warmth, flushing, hiccups."
    },
    {
        "_id": "11",
        "additionalinformations": "Paracetamol is contained in Paracetamol Suspension and other over-the-counter drugs. \r\n\r\nConsult with parent/guardian in relation to medication prior to arrival on scene.\r\n\r\nFor PR use, be aware of modesty of patient, should be administered in presence of a 2nd person.\r\n\r\nIf Paracetamol administered in previous 4 hours, adjust the dose downward by the amount given by other sources resulting in a maximum of 20 mg/Kg.",
        "adultdose": "1 g PO.",
        "contraindications": "KSAR, chronic liver disease, < 1 month old.",
        "indications": "Pyrexia, minor or moderate pain (1 - 6 on pain scale) for adult and paediatric patients.",
        "mdccreatedate": "20/09/2013 07:10:37",
        "mdcid": "11",
        "mdcmodifieddate": "13/04/2015 01:14:17",
        "medicinename": "Paracetamol",
        "paediatricdose": "> 1 month < 1 year: 90 mg PR (AP). \r\n1-3 years: 180 mg PR (AP).\r\n4-8 years: 360 mg PR (AP).\r\n\r\n20 mg/Kg PO (AP, P & EMT).",
        "sideeffects": "Nil."
    },
    {
        "_id": "12",
        "additionalinformations": "NaCl is the IV/IO fluid of choice for pre-hospital emergency care.\r\n\r\nFor KVO use 500 mL pack only.",
        "adultdose": "Keep vein open (KVO) or medication flush for cardiac arrest prn.\r\n\r\nCrush injury, suspension trauma, PEA or Asystole: 20 mL/Kg IV/IO infusion.\r\n\r\nHypothermia: 250 mL IV/IO infusion (warmed to 40 degrees Celsius approx), repeat to max 1 L.\r\n\r\n# neck of femur, sepsis, symptomatic bradycardia: 250 mL IV infusion.\r\n\r\nDecompression illness, sepsis with poor perfusion: 500 mL IV/IO infusion.\r\n\r\nShock from blood loss: 500 mL IV/IO infusion. Repeat in aliquots of 250 mL prn to maintain systolic BP of 90 – 100 mmHg, 120 mmHg (head injury GCS ≤ 8).\r\n\r\nBurns: \r\n> 25% TBSA and/or 1 hour from time of injury to ED, 1,000 mL IV/IO infusion.\r\n> 10% TBSA consider 500 mL IV/IO infusion\r\n\r\nAdrenal insufficiency, glycaemic emergency, heat-related emergency, Sickle Cell Crisis: 1,000 mL IV/IO infusion.\r\n\r\nAnaphylaxis: 1,000 mL IV/IO infusion, repeat x 1 prn.\r\n\r\nPost-resuscitation care: 1,000 mL IV/IO infusion (at 4 degrees Celsius approx). If persistent hypotension, maintain Sys BP > 90 mmHg.",
        "contraindications": "KSAR.",
        "indications": "IV/IO fluid for pre-hospital emergency care.",
        "mdccreatedate": "20/09/2013 07:10:37",
        "mdcid": "12",
        "mdcmodifieddate": "17/11/2014 12:03:50",
        "medicinename": "Sodium Chloride 0.9%",
        "paediatricdose": "Keep vein open (KVO) or medication flush for cardiac arrest prn.\r\n\r\nGlycaemic emergency, neonatal resuscitation, Sickle Cell Crisis: 10 mL/Kg IV/IO infusion.\r\n\r\nHypothermia: 10 mL/Kg IV/IO infusion (warmed to 40 degrees Celsius approx), repeat x 1 prn.\r\n\r\nHaemorrhagic shock: 10 mL/Kg IV/IO, repeat prn if signs of inadequate perfusion.\r\n\r\nAnaphylaxis: 20 mL/Kg IV/IO infusion, repeat x 1 prn.\r\n\r\nAdrenal insufficiency, crush injury, septic shock, suspension trauma, symptomatic bradycardia, Asystole/PEA: 20 mL/Kg IV/IO infusion.\r\n\r\nPost-resuscitation care: 20 mL/Kg IV/IO infusion if persistent poor perfusion.\r\n\r\nBurns: \r\n> 10% TBSA and/or > 1 hour from time of injury to ED:\r\n5 – 10 years: 250 mL IV/IO.\r\n> 10 years: 500 mL IV/IO.",
        "sideeffects": "Excessive volume replacement may lead to heart failure."
    },
    {
        "_id": "13",
        "additionalinformations": "Aspirin 300 mg is indicated for cardiac chest pain regardless if patient has taken anticoagulants or is already on Aspirin. \r\n\r\nIf the patient has swallowed an Aspirin (enteric coated) preparation without chewing it, the patient should be regarded as not having taken any Aspirin; administer 300 mg PO.",
        "adultdose": "300 mg tablet PO.",
        "contraindications": "Active symptomatic gastrointestinal (GI) ulcer, bleeding disorder (e.g. haemophilia), KSAR, patients < 16 years.",
        "indications": "Cardiac chest pain or suspected Myocardial Infarction (MI).",
        "mdccreatedate": "20/09/2013 09:24:52",
        "mdcid": "13",
        "mdcmodifieddate": "17/11/2014 11:15:42",
        "medicinename": "Aspirin",
        "paediatricdose": "Contraindicated.",
        "sideeffects": "Epigastric pain and discomfort, bronchospasm, gastrointestinal haemorrhage."
    },
    {
        "_id": "14",
        "additionalinformations": "Accidental exposure to eyes causes blurred vision.",
        "adultdose": "Cholinergic poison with bradycardia and salivation: 1 mg IV. Repeat at 5 min intervals to ensure minimal salivary secretions.\r\n\r\nSymptomatic Bradycardia: 0.6 mg (600 mcg) IV. Repeat at 3-5 min intervals to Max 3 mg.",
        "contraindications": "KSAR, post-cardiac transplantation.",
        "indications": "Symptomatic bradycardia,\r\nCholinergic poison with bradycardia and salivation.",
        "mdccreatedate": "20/09/2013 09:24:52",
        "mdcid": "14",
        "mdcmodifieddate": "22/10/2014 08:57:46",
        "medicinename": "Atropine",
        "paediatricdose": "Not indicated.",
        "sideeffects": "Tachycardia, dry mouth, dilated pupils."
    },
    {
        "_id": "15",
        "additionalinformations": "Also called Penicillin G.",
        "adultdose": "1,200 mg IV/IO/IM.",
        "contraindications": "KSAR.",
        "indications": "Severe sepsis - Adult.\r\n\r\nSuspected or confirmed meningococcal sepsis - Paediatric.",
        "mdccreatedate": "20/09/2013 09:24:52",
        "mdcid": "15",
        "mdcmodifieddate": "03/11/2014 12:29:21",
        "medicinename": "Benzylpenicillin",
        "paediatricdose": "< 1 yr: 300 mg IV/IO/IM.\r\n1-8 yrs: 600 mg IV/IO/IM.\r\n> 8 yrs: 1,200 mg IV/IO/IM.",
        "sideeffects": "Gastrointestinal disturbances, hypersensitivity reactions."
    },
    {
        "_id": "16",
        "additionalinformations": "",
        "adultdose": "50 mg slow IV.",
        "contraindications": "KSAR.",
        "indications": "Management, prevention and treatment of nausea and vomiting.",
        "mdccreatedate": "20/09/2013 09:24:52",
        "mdcid": "17",
        "mdcmodifieddate": "22/10/2014 09:00:27",
        "medicinename": "Cyclizine",
        "paediatricdose": "Not indicated.",
        "sideeffects": "Tachycardia, dry mouth and sedation."
    },
    {
        "_id": "17",
        "additionalinformations": "Be aware of modesty of patient. \r\n\r\nShould be administered in the presence of a 2nd person.\r\n\r\nEgg and soya proteins are used in the manufacture of diazepam rectal solution; allergies to these proteins may be encountered. \r\n\r\nThe maximum dose of Diazepam includes that administered by carer prior to arrival of Practitioner.",
        "adultdose": "10 mg PR (repeat x 1 prn).\r\nMax 20 mg PR.",
        "contraindications": "Respiratory depression, KSAR, shock, depressed vital signs or alcohol related ALoC.",
        "indications": "Seizure.",
        "mdccreatedate": "20/09/2013 09:24:52",
        "mdcid": "18",
        "mdcmodifieddate": "17/11/2014 11:22:48",
        "medicinename": "Diazepam Rectal Solution",
        "paediatricdose": "< 3 years: 2.5 mg PR.\r\n3-7 years: 5 mg PR.\r\n≥ 8 years: 10 mg PR.\r\nRepeat all x 1 after 5 mins if seizure persists or reoccurs.",
        "sideeffects": "Hypotension, respiratory depression, drowsiness and light-headedness (the next day)."
    },
    {
        "_id": "18",
        "additionalinformations": "Do not store above 25 degrees Celsius.\r\n\r\nDo not refrigerate or freeze.\r\n\r\nMedical Practitioners: Due to the significant increased risk of intra-cerebral bleed for patients aged >75 years DO NOT administer IV Enoxaparin. Enoxaparin 0.75 mg/Kg SC (Max 75 mg SC) is the recommended dose and route.",
        "adultdose": "30 mg IV bolus (>75 years:  0.75 mg/Kg SC).",
        "contraindications": "Active major bleeding disorders and conditions with a high risk of uncontrolled haemorrhage, including recent haemorrhagic stroke or subdural haematoma; in jaundice; active gastric or duodenal ulceration; hiatal ulceration; threatened abortion, or retinopathy, hypersensitivity to Enoxaparin or other Low Molecular Weight Heparins, KSAR.",
        "indications": "Acute ST-segment Elevation Myocardial Infarction (STEMI) immediately following the administration of a thrombolytic agent.",
        "mdccreatedate": "20/09/2013 09:24:52",
        "mdcid": "19",
        "mdcmodifieddate": "17/11/2014 11:26:14",
        "medicinename": "Enoxaparin sodium solution",
        "paediatricdose": "Not indicated.",
        "sideeffects": "Pain, haematoma and mild local irritation may follow the subcutaneous injection."
    },
    {
        "_id": "19",
        "additionalinformations": "N.B. Double check the concentration on pack before use.",
        "adultdose": "0.5 mg IM (0.5 mL). \r\n\r\nEMT (and EFR assist patient) 0.3 mg (Auto injector).\r\n\r\nAll: repeat every 5 minutes prn.",
        "contraindications": "Nil.",
        "indications": "Severe anaphylaxis.",
        "mdccreatedate": "20/09/2013 09:24:52",
        "mdcid": "20",
        "mdcmodifieddate": "17/11/2014 03:28:25",
        "medicinename": "Epinephrine (1:1,000)",
        "paediatricdose": "< 6 months: 0.05 mg IM (0.05 mL)  \r\n\r\n6 months to 5 years: 0.125 mg IM (0.13 mL) \r\n\r\n6 to 8 years: 0.25 mg IM (0.25 mL) \r\n\r\n> 8 years: 0.5 mg IM (0.5 mL) \r\n\r\nEMT (and EFR assist patient): \r\n6 months < 10 years: 0.15 mg (Auto injector)\r\n\r\n≥ 10 years: 0.3 mg (Auto injector)\r\n\r\nAll: repeat every 5 minutes prn",
        "sideeffects": "Palpitations, tachyarrthymias, hypertension, angina-like symptoms."
    },
    {
        "_id": "20",
        "additionalinformations": "Protect from light.",
        "adultdose": "40 mg slow IV.",
        "contraindications": "Pregnancy, hypokalaemia, KSAR.",
        "indications": "Pulmonary oedema.",
        "mdccreatedate": "20/09/2013 09:24:52",
        "mdcid": "21",
        "mdcmodifieddate": "28/03/2014 02:56:16",
        "medicinename": "Furosemide injection",
        "paediatricdose": "Not indicated.",
        "sideeffects": "Headache, dizziness, hypotension, arrhythmias, transient deafness, diarrhoea, nausea and vomiting."
    },
    {
        "_id": "21",
        "additionalinformations": "May be ineffective in patients with low stored glycogen e.g. prior use in previous 24 hours, alcoholic patients with liver disease.\r\n\r\nStore in refrigerator.\r\n\r\nProtect from light.",
        "adultdose": "1 mg IM.",
        "contraindications": "Phaechromocytoma, KSAR.",
        "indications": "Hypoglycaemia in patients unable to take oral glucose or unable to gain IV access, with a blood glucose level < 4 mmol/L.",
        "mdccreatedate": "20/09/2013 09:24:52",
        "mdcid": "22",
        "mdcmodifieddate": "05/11/2014 12:20:30",
        "medicinename": "Glucagon",
        "paediatricdose": "≤ 8 years: 0.5 mg IM.\r\n> 8 years: 1 mg IM.",
        "sideeffects": "Rare: may cause hypotension, dizziness, headache, nausea and vomiting."
    },
    {
        "_id": "22",
        "additionalinformations": "Glucose gel will maintain glucose levels once raised but should be used secondary to dextrose to reverse hypoglycaemia.\r\n\r\nProceed with caution: \r\nPatients with airway compromise.\r\nAltered level of consciousness.",
        "adultdose": "10 – 20 g buccal.\r\nRepeat prn.",
        "contraindications": "KSAR.",
        "indications": "Hypoglycaemia, blood glucose < 4 mmol/L.",
        "mdccreatedate": "20/09/2013 09:24:52",
        "mdcid": "23",
        "mdcmodifieddate": "03/11/2014 03:51:02",
        "medicinename": "Glucose Gel",
        "paediatricdose": "≤ 8 years; 5 – 10 g buccal.\r\n> 8 years: 10 – 20 g buccal.\r\nRepeat prn.",
        "sideeffects": "May cause vomiting in patients under 5 if administered too quickly."
    },
    {
        "_id": "23",
        "additionalinformations": "If the pump is new or has not been used for a week or more, the first spray should be released into the air.",
        "adultdose": "Angina or MI: 0.4 mg sublingual (repeat 3-5 min prn, to Max 1.2 mg).\r\n\r\nPulmonary oedema: 0.8 mg sublingual (repeat x 1 prn).",
        "contraindications": "SBP < 90 mmHg, Viagra or other phosphodiesterase type 5 inhibitors (Sildenafil, Tadalafil and Vardenafil) used within previous 24 hours, KSAR.",
        "indications": "Angina, suspected Myocardial Infarction (MI), Advanced Paramedic and Paramedic - pulmonary oedema.",
        "mdccreatedate": "20/09/2013 09:24:52",
        "mdcid": "24",
        "mdcmodifieddate": "03/11/2014 03:53:25",
        "medicinename": "Glyceryl Trinitrate",
        "paediatricdose": "Not indicated.",
        "sideeffects": "Headache, transient hypotension, flushing, dizziness."
    },
    {
        "_id": "24",
        "additionalinformations": "Observe caution with patients with history of heart failure.\r\n\r\nAlso called Sodium Lactate Intravenous Solution or Compound Ringer Lactate Solution for Injection.\r\n\r\nWarm fluids prior to administration if possible.",
        "adultdose": "See NaCl.",
        "contraindications": "KSAR.",
        "indications": "When NaCl is unavailable it may be substituted with Hartmann’s Solution IV/IO, except for crush injuries, burns, renal failure and hyperglycaemia.",
        "mdccreatedate": "20/09/2013 09:24:52",
        "mdcid": "25",
        "mdcmodifieddate": "03/11/2014 03:54:08",
        "medicinename": "Hartmann’s Solution",
        "paediatricdose": "See NaCl.",
        "sideeffects": "If administered in large amounts may cause oedema."
    },
    {
        "_id": "25",
        "additionalinformations": "Intramuscular injection should avoid the deltoid area because of the possibility of tissue atrophy.\r\n\r\nDosage should not be less than 25 mg.\r\n\r\nIV is the preferred route for adrenal crisis.",
        "adultdose": "Anaphylactic reaction and exacerbation of COPD (AP): 200 mg IV (infusion in 100 mL NaCl) or IM.\r\n\r\nAsthma (AP):\r\n100 mg IV (infusion in 100 mL NaCl).\r\n\r\nAdrenal insufficiency (P & AP):\r\n100 mg IV (infusion in 100 mL NaCl) or IM.",
        "contraindications": "No major contraindications in acute management of anaphylaxis.",
        "indications": "Severe or recurrent anaphylactic reactions.\r\n\r\nAsthma refractory to Salbutamol and Ipratropium Bromide.\r\n\r\nExacerbation of COPD (AP).\r\n\r\nAdrenal insufficiency (P).",
        "mdccreatedate": "20/09/2013 09:24:52",
        "mdcid": "26",
        "mdcmodifieddate": "03/11/2014 01:05:37",
        "medicinename": "Hydrocortisone",
        "paediatricdose": "Anaphylactic reaction (AP):\r\n< 1 year: 25 mg IV (infusion in 100 mL NaCl) or IM.\r\n1 to 5 years: 50 mg IV (infusion in 100 mL NaCl) or IM.\r\n> 5 years: 100 mg IV (infusion in 100 mL NaCl) or IM.\r\n\r\nAsthma (AP):\r\n< 1 year: 25 mg IV (infusion in 100 mL NaCl).\r\n1 to 5 years: 50 mg IV (infusion in 100 mL NaCl).\r\n> 5 years: 100 mg IV (infusion in 100 mL NaCl).\r\n\r\nAdrenal insufficiency (P & AP):\r\n6 months to ≤ 5 years: 50 mg IV (AP) (infusion in 100 mL NaCl) or IM (P).\r\n> 5 years: 100 mg IV (AP) (infusion in 100 mL NaCl) or IM (P).",
        "sideeffects": "CCF, hypertension, abdominal distension, vertigo, headache, nausea, malaise, hiccups."
    },
    {
        "_id": "26",
        "additionalinformations": "",
        "adultdose": "0.5 mg NEB.",
        "contraindications": "KSAR.",
        "indications": "Acute moderate asthma or exacerbation of COPD not responding to initial Salbutamol dose.",
        "mdccreatedate": "20/09/2013 09:24:52",
        "mdcid": "27",
        "mdcmodifieddate": "22/10/2014 09:59:34",
        "medicinename": "Ipratropium Bromide",
        "paediatricdose": "< 12 years: 0.25 mg NEB.\r\n≥ 12 years: 0.5 mg NEB.",
        "sideeffects": "Transient dry mouth, blurred vision, tachycardia, headache."
    },
    {
        "_id": "27",
        "additionalinformations": "Lidocaine may not be administered if Amiodarone has been administered.",
        "adultdose": "1 - 1.5 mg/Kg IV/IO (Max: 3 mg/Kg).",
        "contraindications": "No contraindications for cardiac arrest.",
        "indications": "When Amiodarone is unavailable it may be substituted with Lidocaine for VF/VT arrests.",
        "mdccreatedate": "20/09/2013 09:24:52",
        "mdcid": "28",
        "mdcmodifieddate": "23/09/2014 08:29:55",
        "medicinename": "Lidocaine",
        "paediatricdose": "Not indicated.",
        "sideeffects": "Drowsiness, dizziness, twitching, paraesthesia, convulsions, bradycardia, respiratory depression."
    },
    {
        "_id": "28",
        "additionalinformations": "",
        "adultdose": "2 mg PO.",
        "contraindications": "History of sensitivity to benzodiazepines, severe hepatic or pulmonary insufficiency, suspected significant alcohol and/or sedatives ingested, KSAR.",
        "indications": "Combative with hallucinations or paranoia and risk to self or others.",
        "mdccreatedate": "20/09/2013 09:24:52",
        "mdcid": "29",
        "mdcmodifieddate": "23/09/2014 08:31:50",
        "medicinename": "Lorazepam",
        "paediatricdose": "Not indicated.",
        "sideeffects": "Drowsiness, confusion, headache, dizziness, blurred vision and nausea/vomiting.\r\n\r\nOn rare occasions – hypotension, hypertension."
    },
    {
        "_id": "29",
        "additionalinformations": "",
        "adultdose": "Pulseless torsades de points: 2 g IV/IO.\r\n\r\nTorsades de pointes: 2 g IV (infusion in 100 mL NaCl).\r\n\r\nPersistent bronchospasm: 2 g IV (infusion in 100 mL NaCl).\r\n\r\nSeizure associated with pre-eclampsia: 4 g IV (infusion in 100 mL NaCl).",
        "contraindications": "None in cardiac arrest, KSAR.",
        "indications": "Torsades de pointes, persistent bronchospasm, seizure associated with eclampsia.",
        "mdccreatedate": "20/09/2013 09:24:52",
        "mdcid": "30",
        "mdcmodifieddate": "03/11/2014 12:47:45",
        "medicinename": "Magnesium Sulphate Injection",
        "paediatricdose": "Not indicated.",
        "sideeffects": "Decreased deep-tendon reflexes, respiratory depression, bradycardia, hypothermia."
    },
    {
        "_id": "30",
        "additionalinformations": "Close monitoring of maternal pulse and BP is required and continuous foetal monitoring should be carried out if possible.",
        "adultdose": "20 mg PO.",
        "contraindications": "Hypotension, KSAR.",
        "indications": "Prolapsed cord.",
        "mdccreatedate": "20/09/2013 09:24:52",
        "mdcid": "31",
        "mdcmodifieddate": "04/12/2013 03:30:29",
        "medicinename": "Nifedipine",
        "paediatricdose": "Not indicated.",
        "sideeffects": "Hypotension, headache, bradycardia, nausea and vomiting."
    },
    {
        "_id": "31",
        "additionalinformations": "Do not use if patient unable to understand instructions.\r\n\r\nIn cold temperatures warm cylinder and invert to ensure mix of gases.\r\n\r\nAdvanced Paramedics may use discretion with minor chest injuries.\r\n\r\nBrand name: Entonox®.\r\n\r\nHas an addictive property.\r\n\r\nCaution when using Entonox for greater than one hour for Sickle Cell Crisis.",
        "adultdose": "Self-administered until pain relieved.",
        "contraindications": "ALoC, chest injury/pneumothorax, shock, recent scuba dive, decompression sickness, intestinal obstruction, inhalation injury, carbon monoxide poisoning, KSAR.",
        "indications": "Pain relief.",
        "mdccreatedate": "20/09/2013 09:24:52",
        "mdcid": "32",
        "mdcmodifieddate": "22/09/2014 02:36:02",
        "medicinename": "Nitrous Oxide 50% & Oxygen 50%",
        "paediatricdose": "Self-administered until pain relieved.",
        "sideeffects": "Disinhibition, decreased levels of consciousness, light headedness."
    },
    {
        "_id": "32",
        "additionalinformations": "A written record must be made of what Oxygen therapy is given to every patient.\r\n\r\nDocumentation recording oximetry measurements should state whether the patient is breathing air or a specified dose of supplemental Oxygen.\r\n\r\nConsider humidifier if Oxygen therapy for paediatric patients is > 30 minute duration.\r\n\r\nCaution with paraquat poisoning, administer Oxygen if SpO2 < 92%.\r\n\r\nAvoid naked flames, powerful oxidising agent.",
        "adultdose": "Cardiac and respiratory arrest or Sickle Cell Crisis: 100%.\r\n\r\nLife threats identified during primary survey: 100% until a reliable SpO2 measurement obtained then titrate O2 to achieve SpO2 of 94% - 98%.\r\n\r\nFor patients with acute exacerbation of COPD, administer O2 titrate to achieve SpO2 92% or as specified on COPD Oxygen Alert Card.\r\n\r\nAll other acute medical and trauma titrate O2 to achieve SpO2 94% -98%.",
        "contraindications": "Bleomycin lung injury.",
        "indications": "Absent/inadequate ventilation following an acute medical or traumatic event.\r\n\r\nSpO2 < 94% adults and < 96% paediatrics, SpO2 < 92% for patients with acute exacerbation of COPD.",
        "mdccreatedate": "20/09/2013 09:24:52",
        "mdcid": "33",
        "mdcmodifieddate": "17/11/2014 03:37:34",
        "medicinename": "Oxygen",
        "paediatricdose": "Cardiac and respiratory arrest or Sickle Cell Crisis: 100%.\r\n\r\nLife threats identified during primary survey: 100% until a reliable SpO2 measurement obtained then titrate O2 to achieve SpO2 of 96% - 98%.\r\n\r\nAll other acute medical and trauma titrate O2 to achieve SpO2 of 96% - 98%.",
        "sideeffects": "Prolonged use of O2 with chronic COPD patients may lead to reduction in ventilation stimulus."
    },
    {
        "_id": "33",
        "additionalinformations": "It is more efficient to use a volumizer in conjunction with an aerosol inhaler when administering Salbutamol.\r\n\r\nIf an Oxygen driven nebuliser is used to administer Salbutamol for a patient with acute exacerbation of COPD it should be limited to 6 minutes maximum.",
        "adultdose": "5 mg NEB (or 0.1 mg metered aerosol spray x 5).\r\n(repeat at 5 min prn).",
        "contraindications": "KSAR.",
        "indications": "Bronchospasm, Exacerbation of COPD, Respiratory distress following submersion incident.",
        "mdccreatedate": "20/09/2013 09:24:52",
        "mdcid": "34",
        "mdcmodifieddate": "03/11/2014 01:10:04",
        "medicinename": "Salbutamol",
        "paediatricdose": "< 5 years: 2.5 mg NEB (or 0.1 mg metered aerosol spray x 3).\r\n≥ 5 years: 5 mg NEB (or 0.1 mg metered aerosol spray x 5).\r\n(repeat at 5 min prn).",
        "sideeffects": "Tachycardia, tremors, tachyarrhythmias, high doses may cause hypokalaemia."
    },
    {
        "_id": "34",
        "additionalinformations": "",
        "adultdose": "1 mEq/Kg (1mL/Kg 8.4% solution). Max 50 mEq (50 mL 8.4%).",
        "contraindications": "KSAR.",
        "indications": "Wide complex QRS arrhythmias and/or seizures following Tricyclic antidepressant (TCA) overdose, cardiac arrest following Tricyclic overdose, cardiac arrest following harness induced suspension trauma.",
        "mdccreatedate": "20/09/2013 09:24:52",
        "mdcid": "35",
        "mdcmodifieddate": "03/11/2014 03:30:36",
        "medicinename": "Sodium Bicarbonate",
        "paediatricdose": "Not indicated.",
        "sideeffects": "Nil when used for emergencies."
    },
    {
        "_id": "35",
        "additionalinformations": "Ensure that a second foetus is not in the uterus prior to administration.",
        "adultdose": "1 mL IM.",
        "contraindications": "Severe kidney, liver or cardiac dysfunction, sepsis, KSAR.",
        "indications": "Control of post partum haemorrhage.",
        "mdccreatedate": "20/09/2013 09:24:52",
        "mdcid": "36",
        "mdcmodifieddate": "22/09/2014 02:46:54",
        "medicinename": "Syntometrine",
        "paediatricdose": "Not indicated.",
        "sideeffects": "Nausea and vomiting, abdominal pain, headache, dizziness, cardiac arrhythmias."
    },
    {
        "_id": "36",
        "additionalinformations": "Enoxaparin should be used as antithrombotic adjunctive therapy.",
        "adultdose": "< 60 Kg: 30 mg (6 mL).\r\n≥ 60 < 70 Kg: 35 mg (7 mL).\r\n≥ 70 < 80 Kg: 40 mg (8 mL).\r\n≥ 80 < 90 Kg: 45 mg (9 mL).\r\n≥ 90 Kg: 50 mg (10 mL).",
        "contraindications": "Haemorrhagic stroke or stroke of unknown origin at any time.\r\nIschaemic stroke in previous 6 months.\r\nCentral nervous system damage or neoplasms.\r\nRecent major trauma/surgery/head injury (within 3 weeks).\r\nGastro-intestinal bleeding within the last month.\r\nActive peptic ulcer.\r\nKnown bleeding disorder.\r\nOral anticoagulant therapy.\r\nAortic dissection.\r\nTransient ischaemic attack in preceding 6 months.\r\nPregnancy and within one week post-partum.\r\nNon-compressible punctures.\r\nTraumatic resuscitation.\r\nRefractory hypertension (Sys BP > 180 mmHg).\r\nAdvanced liver disease.\r\nInfective endocarditis.",
        "indications": "Patient conscious, coherent and understands therapy.\r\nPatient consent obtained.\r\nConfirmed STEMI.\r\nPatient not suitable for PPCI from a time or clinical perspective.",
        "mdccreatedate": "20/09/2013 09:24:52",
        "mdcid": "37",
        "mdcmodifieddate": "03/11/2014 03:37:03",
        "medicinename": "Tenecteplase",
        "paediatricdose": "Not indicated.",
        "sideeffects": "Haemorrhage predominantly superficial at the injection site, ecchymoses are observed commonly but usually do not require any specific action, stroke (including intracranial bleeding) and other serious bleeding episodes."
    },
    {
        "_id": "37",
        "additionalinformations": "Special authorisation: Advanced Paramedics and Paramedics are authorised to administer Ticagrelor 180 mg PO following identification of STEMI and medical practitioner instruction.\r\n\r\nIf a patient has been loaded with an anti-platelet medication (other than Aspirin), prior to the arrival of the practitioner, the patient should not have Ticagrelor administered.",
        "adultdose": "Loading dose of 180 mg PO.",
        "contraindications": "Hypersensitivity to the active substance (Ticagrelor) or to any of the excipients, active pathological bleeding, history of intracranial haemorrhage, moderate to severe hepatic impairment.",
        "indications": "Identification of ST Elevation Myocardial Infarction (STEMI) if transporting to PPCI centre.",
        "mdccreatedate": "02/12/2013 02:55:02",
        "mdcid": "60",
        "mdcmodifieddate": "08/04/2015 01:00:33",
        "medicinename": "Ticagrelor",
        "paediatricdose": "Not indicated.",
        "sideeffects": "Dyspnoea, epistaxis, gastrointestinal haemorrhage, subcutaneous or dermal bleeding, bruising and procedural site haemorrhage. \r\n\r\nOther undesirable effects include intracranial bleeding, elevations of serum creatinine and uric acid levels. Consult SmPC for a full list of undesirable effects."
    },
    {
        "_id": "38",
        "additionalinformations": "Caution with head injury.",
        "adultdose": "1 g IV/IO (infusion in 100 mL NaCl).",
        "contraindications": "Hypersensitivity to the active substance or to any of the excipients, acute venous or arterial thrombosis, history of convulsions, severe hepatic impairment.",
        "indications": "Suspected significant internal or external haemorrhage associated with trauma.",
        "mdccreatedate": "21/03/2014 11:20:05",
        "mdcid": "65",
        "mdcmodifieddate": "03/11/2014 01:45:20",
        "medicinename": "Tranexamic Acid",
        "paediatricdose": "Not indicated.",
        "sideeffects": "Diarrhoea, vomiting, nausea.\r\n\r\nOther undesirable effects include visual disturbance, impaired coloured vision, dizziness and headache."
    },
    {
        "_id": "39",
        "additionalinformations": "If a patient has been loaded with an anti-platelet medication (other than Aspirin), prior to the arrival of the practitioner, the patient should not be administered Clopidogrel.",
        "adultdose": "300 mg PO.\r\n≥ 75 years: 75 mg PO.",
        "contraindications": "KSAR, active pathological bleeding, severe liver impairment.",
        "indications": "ST Elevation Myocardial Infarction (STEMI) if patient is not suitable for PPCI.",
        "mdccreatedate": "21/03/2014 11:25:42",
        "mdcid": "66",
        "mdcmodifieddate": "17/11/2014 11:19:21",
        "medicinename": "Clopidogrel",
        "paediatricdose": "Not indicated.",
        "sideeffects": "Abdominal pain, dyspepsia, diarrhoea."
    },
    {
        "_id": "40",
        "additionalinformations": "Paramedics are authorised to continue the established infusion in the absence of an Advanced Paramedic or doctor during transportation.",
        "adultdose": "Dilute appropriate dose of Amiodarone in 100 mL or 500 mL.",
        "contraindications": "KSAR.",
        "indications": "Use as a dilutant for Amiodarone infusion.",
        "mdccreatedate": "21/03/2014 11:31:09",
        "mdcid": "67",
        "mdcmodifieddate": "17/11/2014 11:20:13",
        "medicinename": "Dextrose 5% solution",
        "paediatricdose": "Not indicated.",
        "sideeffects": "Necrosis of tissue around IV access."
    },
    {
        "_id": "41",
        "additionalinformations": "Paracetamol is contained in Paracetamol Suspension and other over-the-counter drugs.\r\n\r\nConsult with parent/guardian in relation to medication prior to arrival on scene.\r\n\r\nIf Paracetamol administered in previous 4 hours, adjust the dose downward by the amount given by other sources resulting in a maximum of 20 mg/Kg.",
        "adultdose": "1 g PO.",
        "contraindications": "KSAR, chronic liver disease, < 1 month old.",
        "indications": "Pyrexia, minor or moderate pain (1 - 6 on pain scale) for adult and paediatric patients.",
        "mdccreatedate": "08/04/2014 07:04:46",
        "mdcid": "68",
        "mdcmodifieddate": "17/11/2014 11:46:37",
        "medicinename": "Paracetamol 6+",
        "paediatricdose": "20 mg/Kg PO (AP, P and EMT).",
        "sideeffects": "Nil."
    }
]
